Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 2.53% | 170.17 | 0.7% | $1275.91m | |
| PFE | Pfizer Inc. | 0.50% | 37.47 | 0.9% | $1199.62m | |
| LLY | Eli Lilly & Co. | -0.37% | 211.56 | 1.1% | $1013.13m | |
| ABBV | AbbVie, Inc. | -0.87% | 109.54 | 1.9% | $754.30m | |
| AZN | AstraZeneca Plc | 0.57% | 54.32 | 1.2% | $708.39m | |
| BMY | Bristol-Myers Squibb Co. | 0.06% | 64.87 | 1.0% | $703.18m | |
| MRK | Merck & Co., Inc. | -0.84% | 80.47 | 0.7% | $702.03m | |
| ARCT | Arcturus Therapeutics Holdings, Inc. | -4.30% | 66.46 | 0.0% | $227.86m | |
| VTRS | Viatris, Inc. | -0.55% | 17.14 | 0.0% | $197.12m | |
| RPRX | Royalty Pharma Plc | 2.00% | 52.53 | 0.2% | $184.46m | |
| NVS | Novartis AG | -3.21% | 95.31 | 0.2% | $183.81m | |
| GRTS | Gritstone Oncology, Inc. | -11.86% | 21.03 | 0.0% | $166.38m | |
| GSK | GlaxoSmithKline Plc | 0.59% | 39.15 | 0.2% | $163.00m | |
| SNY | Sanofi | -1.23% | 49.02 | 0.2% | $137.24m | |
| TAK | Takeda Pharmaceutical Co., Ltd. | -0.05% | 18.36 | 0.0% | $81.21m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.